IFNG-L	Diffuse Large B Cell Lymphoma	IFNG-L	Diffuse Large B Cell Lymphoma	relmacabtagene autoleucel Sensitive: C3 – Early Trials relmacabtagene autoleucel Sensitive : C3	relmacabtagene autoleucel Sensitive: C3 – Early Trials relmacabtagene autoleucel Sensitive : C3
IFNG-L	Cholangiocarcinoma	IFNG-L	Cholangiocarcinoma	bexmarilimab Sensitive: C3 – Early Trials bexmarilimab Sensitive : C3	bexmarilimab Sensitive: C3 – Early Trials bexmarilimab Sensitive : C3
IFNG-L	Melanoma	IFNG-L	Melanoma	bexmarilimab Sensitive: C3 – Early Trials bexmarilimab Sensitive : C3	bexmarilimab Sensitive: C3 – Early Trials bexmarilimab Sensitive : C3
IFNG-L	Gastric Cancer	IFNG-L	Gastric Cancer	bexmarilimab Sensitive: C3 – Early Trials bexmarilimab Sensitive : C3	bexmarilimab Sensitive: C3 – Early Trials bexmarilimab Sensitive : C3
IFNG-L	Esophageal Squamous Cell Carcinoma	IFNG-L	Esophageal Squamous Cell Carcinoma	toripalimab-tpzi Sensitive: C3 – Early Trials toripalimab-tpzi Sensitive : C3	toripalimab-tpzi Sensitive: C3 – Early Trials toripalimab-tpzi Sensitive : C3

IFNG-L

Associations